ES2753148T3 - Método para determinar el peso del recubrimiento que va a ser aplicado para formar una forma de dosificación de liberación controlada - Google Patents

Método para determinar el peso del recubrimiento que va a ser aplicado para formar una forma de dosificación de liberación controlada Download PDF

Info

Publication number
ES2753148T3
ES2753148T3 ES08725289T ES08725289T ES2753148T3 ES 2753148 T3 ES2753148 T3 ES 2753148T3 ES 08725289 T ES08725289 T ES 08725289T ES 08725289 T ES08725289 T ES 08725289T ES 2753148 T3 ES2753148 T3 ES 2753148T3
Authority
ES
Spain
Prior art keywords
spherical particles
coating
substantially spherical
surface area
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08725289T
Other languages
English (en)
Spanish (es)
Inventor
Orpapin Rubino
David Jones
Robert Femia
Oliver Mueller
Narayan Rangunathan
Norbert Pollinger
Armin Prasch
Anne Ettner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glatt Air Techniques Inc
Original Assignee
Glatt Air Techniques Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glatt Air Techniques Inc filed Critical Glatt Air Techniques Inc
Application granted granted Critical
Publication of ES2753148T3 publication Critical patent/ES2753148T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/005—Coating of tablets or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES08725289T 2007-02-23 2008-02-06 Método para determinar el peso del recubrimiento que va a ser aplicado para formar una forma de dosificación de liberación controlada Active ES2753148T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90322407P 2007-02-23 2007-02-23
PCT/US2008/001639 WO2008103245A2 (en) 2007-02-23 2008-02-06 Method of determining the weight of the coating to be applied to form a controlled release dosage form

Publications (1)

Publication Number Publication Date
ES2753148T3 true ES2753148T3 (es) 2020-04-07

Family

ID=39710638

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08725289T Active ES2753148T3 (es) 2007-02-23 2008-02-06 Método para determinar el peso del recubrimiento que va a ser aplicado para formar una forma de dosificación de liberación controlada

Country Status (7)

Country Link
US (1) US20110014295A1 (zh)
EP (1) EP2120881B1 (zh)
JP (1) JP2010519295A (zh)
CN (2) CN101668513A (zh)
CA (1) CA2678956C (zh)
ES (1) ES2753148T3 (zh)
WO (1) WO2008103245A2 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014030204A1 (ja) * 2012-08-20 2014-02-27 大日本住友製薬株式会社 薬物含有中空粒子
WO2021263132A1 (en) 2020-06-26 2021-12-30 Aprecia Pharmaceuticals LLC Rapidly-orodispersible tablets having an interior cavity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
CA1293449C (en) * 1985-10-11 1991-12-24 Lars-Erik David Dahlinder Controlled release drug preparation
US5527545A (en) * 1989-09-18 1996-06-18 Recordati S.A. Chemical And Pharmaceutical Company Liquid-suspension controlled-release pharmaceutical composition
IT1264020B (it) * 1993-01-28 1996-09-09 Recordati Chem Pharm Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi
SE0100824D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method III to obtain microparticles
EP1755557A4 (en) * 2004-05-19 2007-08-29 Glatt Air Tech Inc GRANULES CONTAINING MICROGRANULES AND PROCESS FOR THE PREPARATION THEREOF
US20060099259A1 (en) * 2004-11-05 2006-05-11 Grant Heinicke Propranolol formulations
US20070082050A1 (en) * 2005-05-31 2007-04-12 Cherukuri S R Modified release formulations of antihypertensive drugs
CN100348195C (zh) * 2005-10-30 2007-11-14 山东瑞阳制药有限公司 复方降压制剂

Also Published As

Publication number Publication date
CA2678956A1 (en) 2008-08-28
CN103919753A (zh) 2014-07-16
EP2120881B1 (en) 2019-08-07
EP2120881A2 (en) 2009-11-25
JP2010519295A (ja) 2010-06-03
EP2120881A4 (en) 2012-11-07
CA2678956C (en) 2013-11-19
WO2008103245A2 (en) 2008-08-28
CN101668513A (zh) 2010-03-10
WO2008103245A3 (en) 2008-12-04
US20110014295A1 (en) 2011-01-20

Similar Documents

Publication Publication Date Title
CN103118668B (zh) 黏结剂在制备贮藏稳定的制剂中的用途
Garg et al. Gastroretentive floating microspheres of silymarin: preparation and in vitro evaluation
ES2661062T3 (es) Procedimiento de preparación de partículas huecas y sus aplicaciones
Mali et al. Novel study in sustained release drug delivery system: A Review
ES2753148T3 (es) Método para determinar el peso del recubrimiento que va a ser aplicado para formar una forma de dosificación de liberación controlada
Jalil Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer
CA2900781A1 (en) Multiparticulate pharmaceutical composition comprising a multitude of two kinds of pellets
Choudhary et al. Evaluation and optimization of preparative variables for controlled-release floating microspheres of levodopa/carbidopa
Wang et al. Model drug as pore former for controlled release of water-soluble metoprolol succinate from ethylcellulose-coated pellets without lag phase: opportunities and challenges
Karrout et al. When drugs plasticize film coatings: unusual formulation effects observed with metoprolol and Eudragit RS
Raj et al. Design and evaluation of floating microspheres of pantoprazole sodium
Gavhane et al. A review on microsphere
US20050100606A1 (en) Controlled release formulation of tamsulosin hydrochloride and preparation process thereof
Kouchak et al. Preparation and in vitro evaluation of a microballoon delivery system for theophylline
Purohit et al. Formulation and evaluation of floating microspheres of lovastatin using Eudragit-E and ethyl cellulose by solvent evaporation method
Chhipa et al. Formulation optimization of sustained release pellets of itopride hydrochloride using different polymers
Hashem et al. In Vitro and in vivo evaluation of combined time and pH-dependent oral colonic targeted prednisolone microspheres
Miyazaki et al. Comparison of gastroretentive microspheres and sustained‐release preparations using theophylline pharmacokinetics
Garg et al. Development and characterization of cellulose and eudragit gastroretentive floating microspheres of acyclovir
Sundar et al. Design development and evaluation of gastro retentive floating microspheres of atazanavir sulfate
Ahmed et al. In vitro release kinetics study of ambroxol hydrochloride pellets developed by extrusion spheronization technique followed by acrylic polymer coating
Akhter et al. Effect of acrylic polymers on physical parameters of spheronized pellets using an aqueous coating system
Surti et al. Formulation and Characterization of Combination therapy based Double Layered Microspheres of Antihypertensive Drugs
Gami et al. DESIGN AND EVALUATION STUDY OF PULSATILE RELEASE TABLETS OF METOPROLOL SUCCINATE.
Tangde et al. Sustained release matrix type drug delivery systems; a review